SamanTree Medical: A Breakthrough in Real-Time Surgical Imaging

Deal News | Apr 09, 2025 | Karista SAS

SamanTree Medical is revolutionizing surgical oncology with its innovative Histolog scanner. This device, already utilized in over 5,000 surgeries, provides real-time, high-resolution imaging of fresh tissues using massive parallel confocal microscopy. It assists surgeons in accurately assessing surgical margins on the spot, thereby reducing the need for re-operations and improving surgical outcomes. Karista, a private equity firm, was attracted to SamanTree's potential to transform the field of surgical oncology. Their investment was driven by the Histolog scanner's ability to address a significant need for immediate, precise margin assessments, offering a new gold standard for intraoperative precision.

Sectors

Medical Devices
Healthcare
Private Equity

Geography

Global – The article discusses a technology (Histolog scanner) that is applicable broadly across surgical practices globally.
France – Karista SAS, the private equity firm investing in SamanTree Medical, is based in France.

Industry

Medical Devices – SamanTree Medical is involved in the development of medical devices, particularly the Histolog scanner used in surgical oncology.
Healthcare – The article focuses on improvements in surgical oncology, which falls within the broader healthcare industry.
Private Equity – Karista SAS, a private equity firm, is making an investment, demonstrating their active participation in funding healthcare advancements.

Financials

Participants

Name	Role	Type	Description
SamanTree Medical	Target Company	Company	A company specializing in creating medical devices for surgical oncology, specifically the Histolog scanner.
Karista SAS	Investor	Company	A private equity firm investing in SamanTree Medical due to the potential of their Histolog scanner.
Amine Benmoussa	Representative of Karista	Person	Discussing Karista's investment motivations in SamanTree Medical.